3-(3-(4-chlorobenzyl)-1,2,4-oxadiazol-5-yl)propan-1-amine hydrochloride, 95.0%, 250mg

2-Amino-4-methylthiazole-5-carboxylic acid methylester, 98.0%, 5g

N-(9-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 98%, 100mg

2-Methyl-2,4-pentandiol, min. 99 %, zur Synthese, 10 l, kunststoffverpackung.

Methyl 2-(5-bromo-2-chlorophenyl)acetate, 95.0%, 5g

2-(2-chloroethyl)-2-azabicyclo[2.2.1]heptane hydrochloride, 95.0%, 5g

2-(1-Methyl-piperazin-2-yl)-ethanol, 95.0%, 250mg

3-(Chloromethyl)-5-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole, 95.0%, 5g

n,2-Dihydroxy-5-methylbenzamide, 97%, 1g

Benzo[d]oxazole-4-carbaldehyde, 95%, 250mg

7-Bromomethyl-4-methyl-chromen-2-one, 1g

Benzotriazole Needle Crystal, 99.8%, 500g

2-(3,4-Dichlorophenoxy)acetic acid, 97%, 1g